Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Joel N H Stern, Ph.D.

TitleInstructor in Oral and Developmental Biology
InstitutionHarvard School of Dental Medicine
DepartmentDevelopmental Biology
AddressHarvard School of Dental Medicine
Developmental Biology REB 413
188 Longwood Ave
Boston MA 02115

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, Vorobjev IA. Circulating microparticles: square the circle. BMC Cell Biol. 2013; 14(1):23.
    View in: PubMed
  2. Petzold C, Schallenberg S, Stern JN, Kretschmer K. Targeted Antigen Delivery to DEC-205(+) Dendritic Cells for Tolerogenic Vaccination. Rev Diabet Stud. 2012; 9(4):305-18.
    View in: PubMed
  3. Tabansky I, Lenarcic A, Draft RW, Loulier K, Keskin DB, Rosains J, Rivera-Feliciano J, Lichtman JW, Livet J, Stern JN, Sanes JR, Eggan K. Developmental bias in cleavage-stage mouse blastomeres. Curr Biol. 2013 Jan 7; 23(1):21-31.
    View in: PubMed
  4. Krzewski K, Gil-Krzewska A, Watts J, Stern JN, Strominger JL. VAMP4- and VAMP7-expressing vesicles are both required for cytotoxic granule exocytosis in NK cells. Eur J Immunol. 2011 Nov; 41(11):3323-9.
    View in: PubMed
  5. Zakka LR, Fradkov E, Keskin DB, Tabansky I, Stern JN, Ahmed AR. The role of natural killer cells in autoimmune blistering diseases. Autoimmunity. 2012 Feb; 45(1):44-54.
    View in: PubMed
  6. Kato Z, Stern JN, Nakamura HK, Miyashita N, Kuwata K, Kondo N, Strominger JL. The autoimmune TCR-Ob.2F3 can bind to MBP85-99/HLA-DR2 having an unconventional mode as in TCR-Ob.1A12. Mol Immunol. 2010 Nov-Dec; 48(1-3):314-20.
    View in: PubMed
  7. Stern JN, Keskin DB, Kato Z, Waldner H, Schallenberg S, Anderson A, von Boehmer H, Kretschmer K, Strominger JL. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc Natl Acad Sci U S A. 2010 Oct 5; 107(40):17280-5.
    View in: PubMed
  8. Encinales L, Zuñiga J, Granados-Montiel J, Yunis M, Granados J, Almeciga I, Clavijo O, Awad C, Collazos V, Vargas-Rojas MI, Bañales-Mendez JL, Vazquez-Castañeda L, Stern JN, Romero V, Fridkis-Hareli M, Frindkis-Hareli M, Terreros D, Fernandez-Viña M, Yunis EJ. Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol. 2010 Feb; 47(5):1066-73.
    View in: PubMed
  9. Zhang H, Stern JN, Strominger JL. T cell receptors in an IL-10-secreting amino acid copolymer-specific regulatory T cell line that mediates bystander immunosuppression. Proc Natl Acad Sci U S A. 2009 Mar 3; 106(9):3336-41.
    View in: PubMed
  10. Stern JN, Keskin DB, Romero V, Zuniga J, Encinales L, Li C, Awad C, Yunis EJ. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res. 2009; 45(1):1-12.
    View in: PubMed
  11. Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol. 2009 Jan; 9(1):10-25.
    View in: PubMed
  12. Chung J, Serezani CH, Huang SK, Stern JN, Keskin DB, Jagirdar R, Brock TG, Aronoff DM, Peters-Golden M. Rap1 activation is required for Fc gamma receptor-dependent phagocytosis. J Immunol. 2008 Oct 15; 181(8):5501-9.
    View in: PubMed
  13. Kato Z, Stern JN, Nakamura HK, Kuwata K, Kondo N, Strominger JL. Positioning of autoimmune TCR-Ob.2F3 and TCR-Ob.3D1 on the MBP85-99/HLA-DR2 complex. Proc Natl Acad Sci U S A. 2008 Oct 7; 105(40):15523-8.
    View in: PubMed
  14. Stern JN, Keskin DB. Strategies for the identification of loci responsible for the pathogenesis of multiple sclerosis. Cell Mol Biol Lett. 2008; 13(4):656-66.
    View in: PubMed
  15. Stern JN, Keskin DB, Barteneva N, Zuniga J, Yunis EJ, Ahmed AR. Possible role of natural killer cells in pemphigus vulgaris - preliminary observations. Clin Exp Immunol. 2008 Jun; 152(3):472-81.
    View in: PubMed
  16. Stern JN, Keskin DB, Zhang H, Lv H, Kato Z, Strominger JL. Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc Natl Acad Sci U S A. 2008 Apr 1; 105(13):5172-6.
    View in: PubMed
  17. Keskin DB, Stern JN, Fridkis-Hareli M, Razzaque Ahmed A. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy. Cytokine. 2008 Mar; 41(3):315-21.
    View in: PubMed
  18. Li C, Ge B, Nicotra M, Stern JN, Kopcow HD, Chen X, Strominger JL. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc Natl Acad Sci U S A. 2008 Feb 26; 105(8):3017-22.
    View in: PubMed
  19. Keskin DB, Allan DS, Rybalov B, Andzelm MM, Stern JN, Kopcow HD, Koopman LA, Strominger JL. TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc Natl Acad Sci U S A. 2007 Feb 27; 104(9):3378-83.
    View in: PubMed
  20. Zuniga J, Romero V, Azocar J, Stern JN, Clavijo O, Almeciga I, Encinales L, Avendano A, Fridkis-Hareli M, Pandey JP, Yunis EJ. Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican Americans. Hum Immunol. 2006 Nov; 67(11):907-14.
    View in: PubMed
  21. Rashid KA, Stern JN, Ahmed AR. Identification of an epitope within human integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid. J Immunol. 2006 Feb 1; 176(3):1968-77.
    View in: PubMed
  22. Zúñiga J, Ilzarbe M, Acunha-Alonzo V, Rosetti F, Herbert Z, Romero V, Almeciga I, Clavijo O, Stern JN, Granados J, Fridkis-Hareli M, Morrison P, Azocar J, Yunis EJ. Allele frequencies for 15 autosomal STR loci and admixture estimates in Puerto Rican Americans. Forensic Sci Int. 2006 Dec 20; 164(2-3):266-70.
    View in: PubMed
  23. Yunis EJ, Zúñiga J, Koka PS, Husain Z, Romero V, Stern JN, Fridkis-Hareli M. Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors. J Stem Cells. 2006; 1(2):125-147.
    View in: PubMed
  24. Illes Z, Stern JN, Keskin DB, Reddy J, Brosnan CF, Waldner H, Santambrogio L, Kuchroo VK, Strominger JL. Copolymer effects on microglia and T cells in the central nervous system of humanized mice. Eur J Immunol. 2005 Dec; 35(12):3683-93.
    View in: PubMed
  25. Stern JN, Illés Z, Reddy J, Keskin DB, Fridkis-Hareli M, Kuchroo VK, Strominger JL. Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2005 Feb 1; 102(5):1620-5.
    View in: PubMed
  26. Illés Z, Stern JN, Reddy J, Waldner H, Mycko MP, Brosnan CF, Ellmerich S, Altmann DM, Santambrogio L, Strominger JL, Kuchroo VK. Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11749-54.
    View in: PubMed
  27. Stern JN, Illés Z, Reddy J, Keskin DB, Sheu E, Fridkis-Hareli M, Nishimura H, Brosnan CF, Santambrogio L, Kuchroo VK, Strominger JL. Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11743-8.
    View in: PubMed
  28. Fridkis-Hareli M, Santambrogio L, Stern JN, Fugger L, Brosnan C, Strominger JL. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. J Clin Invest. 2002 Jun; 109(12):1635-43.
    View in: PubMed
  29. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature. 2002 Jan 31; 415(6871):526-30.
    View in: PubMed
  30. Fridkis-Hareli M, Stern JN, Fugger L, Strominger JL. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses. Hum Immunol. 2001 Aug; 62(8):753-63.
    View in: PubMed
  31. Silva AJ, Elgersma Y, Friedman E, Stern J, Kogan J. A mouse model for learning and memory defects associated with neurofibromatosis type I. Pathol Biol (Paris). 1998 Nov; 46(9):697-8.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Stern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_